Literature DB >> 35173320

COVID reinfections surge during Omicron onslaught.

Smriti Mallapaty.   

Abstract

Entities:  

Keywords:  SARS-CoV-2

Year:  2022        PMID： 35173320     DOI： 10.1038/d41586-022-00438-3

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization.

Authors:  Sandile Cele; Laurelle Jackson; David S Khoury; Khadija Khan; Thandeka Moyo-Gwete; Houriiyah Tegally; James Emmanuel San; Deborah Cromer; Cathrine Scheepers; Daniel G Amoako; Farina Karim; Mallory Bernstein; Gila Lustig; Derseree Archary; Muneerah Smith; Yashica Ganga; Zesuliwe Jule; Kajal Reedoy; Shi-Hsia Hwa; Jennifer Giandhari; Jonathan M Blackburn; Bernadett I Gosnell; Salim S Abdool Karim; Willem Hanekom; Anne von Gottberg; Jinal N Bhiman; Richard J Lessells; Mahomed-Yunus S Moosa; Miles P Davenport; Tulio de Oliveira; Penny L Moore; Alex Sigal
Journal:  Nature       Date:  2021-12-23       Impact factor: 49.962

2.  Protection against the Omicron Variant from Previous SARS-CoV-2 Infection.

Authors:  Heba N Altarawneh; Hiam Chemaitelly; Mohammad R Hasan; Houssein H Ayoub; Suelen Qassim; Sawsan AlMukdad; Peter Coyle; Hadi M Yassine; Hebah A Al-Khatib; Fatiha M Benslimane; Zaina Al-Kanaani; Einas Al-Kuwari; Andrew Jeremijenko; Anvar H Kaleeckal; Ali N Latif; Riyazuddin M Shaik; Hanan F Abdul-Rahim; Gheyath K Nasrallah; Mohamed G Al-Kuwari; Adeel A Butt; Hamad E Al-Romaihi; Mohamed H Al-Thani; Abdullatif Al-Khal; Roberto Bertollini; Patrick Tang; Laith J Abu-Raddad
Journal:  N Engl J Med       Date:  2022-02-09       Impact factor: 91.245
  2 in total
  10 in total

1.  Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022.

Authors:  Chiara Sacco; Daniele Petrone; Martina Del Manso; Alberto Mateo-Urdiales; Massimo Fabiani; Marco Bressi; Antonino Bella; Patrizio Pezzotti; Maria Cristina Rota; Flavia Riccardo
Journal:  Euro Surveill       Date:  2022-05

2.  Differences in Immunological Evasion of the Delta (B.1.617.2) and Omicron (B.1.1.529) SARS-CoV-2 Variants: A Retrospective Study on the Veneto Region's Population.

Authors:  Silvia Cocchio; Federico Zabeo; Giacomo Facchin; Nicolò Piva; Giovanni Venturato; Thomas Marcon; Mario Saia; Michele Tonon; Michele Mongillo; Filippo Da Re; Francesca Russo; Vincenzo Baldo
Journal:  Int J Environ Res Public Health       Date:  2022-07-04       Impact factor: 4.614

3.  Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.

Authors:  Juanjie Tang; Tanya Novak; Julian Hecker; Gabrielle Grubbs; Fatema Tuz Zahra; Lorenza Bellusci; Sara Pourhashemi; Janet Chou; Kristin Moffitt; Natasha B Halasa; Stephanie P Schwartz; Tracie C Walker; Keiko M Tarquinio; Matt S Zinter; Mary A Staat; Shira J Gertz; Natalie Z Cvijanovich; Jennifer E Schuster; Laura L Loftis; Bria M Coates; Elizabeth H Mack; Katherine Irby; Julie C Fitzgerald; Courtney M Rowan; Michele Kong; Heidi R Flori; Aline B Maddux; Steven L Shein; Hillary Crandall; Janet R Hume; Charlotte V Hobbs; Adriana H Tremoulet; Chisato Shimizu; Jane C Burns; Sabrina R Chen; Hye Kyung Moon; Christoph Lange; Adrienne G Randolph; Surender Khurana
Journal:  Nat Commun       Date:  2022-05-27       Impact factor: 17.694

4.  Sequence Proven Reinfections with SARS-CoV-2 at a Large Academic Center.

Authors:  C Paul Morris; Raghda E Eldesouki; Amary Fall; David C Gaston; Julie M Norton; Nicholas Gallagher; Chun Huai Luo; Omar Abdullah; Eili Y Klein; Heba H Mostafa
Journal:  medRxiv       Date:  2022-05-19

Review 5.  The Importance of Vaccination in the Context of the COVID-19 Pandemic: A Brief Update Regarding the Use of Vaccines.

Authors:  Bruna Aparecida Souza Machado; Katharine Valéria Saraiva Hodel; Larissa Moraes Dos Santos Fonseca; Vinícius Couto Pires; Luis Alberto Brêda Mascarenhas; Leone Peter Correia da Silva Andrade; Marcelo Albano Moret; Roberto Badaró
Journal:  Vaccines (Basel)       Date:  2022-04-12

6.  The rapid spread of SARS-COV-2 Omicron variant in Italy reflected early through wastewater surveillance.

Authors:  G La Rosa; M Iaconelli; C Veneri; P Mancini; G Bonanno Ferraro; D Brandtner; L Lucentini; L Bonadonna; M Rossi; M Grigioni; E Suffredini
Journal:  Sci Total Environ       Date:  2022-05-06       Impact factor: 10.753

7.  Policy choices for Shanghai responding to challenges of Omicron.

Authors:  Ying Qian; Siqi Cao; Laijun Zhao; Yuge Yan; Jiaoling Huang
Journal:  Front Public Health       Date:  2022-08-09

Review 8.  RNA Viruses, Pregnancy and Vaccination: Emerging Lessons from COVID-19 and Ebola Virus Disease.

Authors:  Chandrasekharan Rajalekshmi Dhanya; Aswathy Shailaja; Aarcha Shanmugha Mary; Sumodan Padikkala Kandiyil; Ambili Savithri; Vishnu Sasidharan Lathakumari; Jayakrishnan Therthala Veettil; Jiji Joseph Vandanamthadathil; Maya Madhavan
Journal:  Pathogens       Date:  2022-07-15

Review 9.  As the virus evolves, so too must we: a drug developer's perspective : We need a new paradigm in searching for next-generation countermeasures.

Authors:  Fang Flora Fang
Journal:  Virol J       Date:  2022-10-10       Impact factor: 5.913

10.  SARS-CoV-2 reinfections with BA.1 (Omicron) variant among fully vaccinated individuals in northeastern Brazil.

Authors:  Francisco P Freire-Neto; Diego G Teixeira; Dayse C S da Cunha; Ingryd C Morais; Celisa P M Tavares; Genilson P Gurgel; Sanderson D N Medeiros; David C Dos Santos; Alexandre de O Sales; Selma M B Jeronimo
Journal:  PLoS Negl Trop Dis       Date:  2022-10-03
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.